Jordanian royalty to grace Prevent Cancer Foundation 29th Annual Gala
FODER SOFORTIGE FREIGABE
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Washington, D.C. – Marking nearly three decades of honoring nations committed to cancer prevention and early detection, the Prevent Cancer Foundation’s 2023 Gala will pay tribute to Jordan on September 27 at the National Building Museum in Washington, D.C. Her Royal Highness, Princess Ghida Talal of Jordan and Her Excellency, Ambassador Dina Kawar will attend and will be honored during this year’s event, themed Jordan: Pillar of Wonder.
The 2022 Gala was a record-breaking event, raising over $2.2 million for cancer prevention and early detection efforts. This year’s event is on track to be another record-breaking event, with proceeds from the Gala supporting the Foundation’s programs, including research grants and fellowships and community grants. Funds will also support the Foundation’s public education campaigns, including “Early Detection = Better Outcomes,” launched this year to educate Americans on the routine cancer screenings they need and encourage them to schedule appointments, and “Too Young for This Sh*t,” which educates people about the alarming rise of colorectal cancer in young adults.
Continuing with tradition, the Foundation will present the annual Cancer Champion awards. Senators Tom Carper and Shelley Moore Capito are being recognized for their significant contributions to increasing access to prevention and early detection services.
Sen. Carper is a longtime supporter of affordable and accessible health care for all Americans. Along with his significant engagement in the crafting and passage of the Affordable Care Act, he has also committed to tobacco control legislation, providing access to affordable tobacco cessation treatments and extending benefits to firefighters who, in the line of duty, increase their risk of cancer and other diseases.
Sen. Capito is being recognized for her introduction of the Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act to reauthorize the National Breast and Cervical Cancer Early Detection Program, which will ensure more women have access to lifesaving cancer screenings.
Recognized as one of Washington’s premier events and ranked among top Washington charity events, the Gala attracts more than 1,000 guests, including members of Congress and the administration; the diplomatic community; and leaders in business, government, medical, sports, media, social and philanthropic communities.
D.C. media is invited to attend and report on the Gala:
What: Prevent Cancer Annual Gala
When: Wednesday, September 27
Where: National Building Museum, 401 F St. NW, Washington, D.C. 20001
Dress: Business or formal attire
If you plan to attend, please RSVP to kyra.meister@preventcancer.org by Monday, September 25. Please note that members of the press will not be seated for dinner.
A silent auction benefitting cancer research fellowships and community outreach will be held the evening of the event. Bids can be placed online beginning Wednesday, September 15. Learn more about the Prevent Cancer Annual Gala.
The 2023 Prevent Cancer Gala thanks its top sponsors:
Presenting Sponsor:
- Gilead
Diamond:
- Community Oncology Alliance
- Daiichi-Sankyo
- Grail
- Johnson & Johnson
- Pfizer
Platinum:
- Merck
- Novartis
- PhRMA
- Walmart
###
Über die Prevent Cancer Foundation®
Die Stiftung Prevent Cancer® Ist die einzigen USA-basierend gemeinnützige Organisation einzig und allein gewidmet Zu Krebs Prävention und frühzeitige Erkennung. Durch Forschung, Bildung, Reichweite und Interessenvertretung, Wir haben unzähligen Menschen geholfen, eine Krebsdiagnose zu vermeiden oder ihren Krebs früh genug zu erkennen, um eine erfolgreiche Behandlung zu ermöglichen. Was uns antreibt eine Vision einer Welt, in der Krebs vermeidbar ist, nachweisbarer und schlagbar für alle.
Die Stiftung stellt sich der Herausforderung, die Zahl der Krebstoten bis 2035 um 40% zu senken. Um dieses Ziel zu erreichen, wir sind verpflichtet sich, $20 Millionen in innovative Technologien zur Früherkennung von Krebs und zur Mehr-Krebsvorsorge, $10 Millionen zur Ausweitung des Zugangs zu Krebsvorsorge und Impfungen für medizinisch unterversorgte Gemeinden und $10 Millionen, um die Öffentlichkeit über Screening- und Impfmöglichkeiten aufzuklären.
Für weitere Informationen, besuchen Sie bitte www.preventcancer.org.